Efficacy of Ofloxacin in eradication of Helicobacter pylori

Phase 2

• Conditions: Helicobacter Pylori Infection.; Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters

• Registration Number: IRCT2015113025292N1
• Lead Sponsor: Vice chancellor for research, Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

positive biopsies of H. pylori; positive rapid urease test of H. pylori, stomach ulcer; duodenal ulcer; dyspepsia with indications of Helicobacter pylori eradication.
Exclusion criteria: previous treatment for H. pylori; renal failure; receiving antibiotics during the previous last month; cirrhosis; pregnancy; breast feeding; gastric cancer.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
BT (Urease Breath Test). Timepoint: 20 days after completing treatment. Method of measurement: Patients swallow urea labeled with an uncommon isotope, either radioactive carbon-14 or non-radioactive carbon-13. After10 to 30 minutes, the detection of isotope-labeled carbon dioxide in exhaled breath indicates that the urea was split.